
Organic Process Research and Development p. 1897 - 1904 (2012)
Update date:2022-08-25
Topics:
Gillmore, Adam T.
Badland, Matthew
Crook, Clare L.
Castro, Nieves M.
Critcher, Douglas J.
Fussell, Steven J.
Jones, Katherine J.
Jones, Matthew C.
Kougoulos, Eleftherios
Mathew, Jinu S.
McMillan, Lynne
Pearce, John E.
Rawlinson, Fiona L.
Sherlock, Alexandra E.
Walton, Robert
Novel PARP inhibitor 1 is a promising new candidate for treatment of breast and ovarian cancer. A modified synthetic route to 1 has been developed and demonstrated on 7 kg scale. In order to scale up the synthesis to multikilogram scale, several synthetic challenges needed to be overcome. The key issues included significant thermal hazards present in a Leimgruber-Batcho indole synthesis, a low-yielding side-chain installation, a nonrobust Suzuki coupling and hydrogen cyanide generation during a reductive amination. In addition to these issues, changing from intravenous to oral delivery required a new salt form and therefore a new crystallization procedure. This contribution describes development work to solve these issues and scaling up of the new process in the pilot plant.
View More
ChangZhou Mascotchem. Co.,Ltd.
website:http://www.mascotchem.com
Contact:86-519-85010339
Address:B-802,XingBei Building,391#,Tongjiang Middle Road New District,Changzhou,JS,China
Disynthesis Chemical Technology Co. Ltd.
Contact:+86-571-88194596
Address:Dengyun road 380, Gongshu district, Hangzhou city, China
Contact:+86-021-50792271
Address:Building 24A, 300 Chuantu Road, Chuansha, Pudong new area, Shanghai, China, 201202
Dalian Synco Chemical Co., Ltd.
Contact:+86-411-83635150
Address:Rm 1004, 24, Tangshan Street, Dalian
BrightGene Bio-Medical Technology Co., Ltd.
website:https://en.bright-gene.com/
Contact:+86-512-62551801
Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
Doi:10.1021/op050044y
(2005)Doi:10.1021/jacs.9b00341
(2019)Doi:10.1016/S0040-4039(00)70378-9
(1965)Doi:10.1039/c9nj02727k
(2019)Doi:10.1021/jacs.9b02505
(2019)Doi:10.1002/cplu.201500282
(2015)